Racial Variation in Willingness to Trade Financial Resources for Life-Prolonging Cancer Treatment

被引:18
|
作者
Martin, Michelle Y. [1 ]
Pisu, Maria
Oster, Robert A.
Urmie, Julie M. [2 ]
Schrag, Deborah [3 ]
Huskamp, Haiden A. [4 ]
Lee, Jeannette [5 ]
Kiefe, Catarina I. [6 ]
Fouad, Mona N.
机构
[1] Univ Alabama, Dept Med, Div Prevent Med, Sch Med, Birmingham, AL 35294 USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[5] Univ Arkansas, Dept Biostat, Little Rock, AR 72204 USA
[6] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA
关键词
treatment; preferences; cancer; race; financial resources; tradeoffs; CARE OUTCOMES RESEARCH; OF-LIFE; TREATMENT PREFERENCES; ETHNIC-DIFFERENCES; AFRICAN-AMERICAN; ADVANCE DIRECTIVES; WHITE PATIENTS; END; ATTITUDES; SUPPORT;
D O I
10.1002/cncr.25839
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Minority patients receive more aggressive care at the end of life, but it is unclear whether this trend is consistent with their preferences. We compared the willingness to use personal financial resources to extend life among white, black, Hispanic, and Asian cancer patients. METHODS: Patients with newly diagnosed lung or colorectal cancer participating in the Cancer Care Outcomes Research and Surveillance observational study were interviewed about myriad aspects of their care, including their willingness to expend personal financial resources to prolong life. We evaluated the association of race/ethnicity with preference for life-extending treatment controlling for clinical, sociodemographic, and psychosocial factors using logistic regression. RESULTS: Among patients (N = 4214), 80% of blacks reported a willingness to spend all resources to extend life, versus 54% of whites, 69% of Hispanics, and 72% of Asians (P<.001). In multivariate analyses, blacks were more likely to opt for expending all financial resources to extend life than whites (odds ratio, 2.41; 95% confidence interval, 1.84-3.17; P < .001). CONCLUSIONS: Black cancer patients are more willing to exhaust personal financial resources to extend life. Delivering quality cancer care requires an understanding of how these preferences impact cancer care and outcomes. Cancer 2011;117:3476-84. (C) 2011 American Cancer Society.
引用
收藏
页码:3476 / 3484
页数:9
相关论文
共 50 条
  • [21] ETHICS CONSULTANTS RECOMMENDATIONS FOR LIFE-PROLONGING TREATMENT OF PATIENTS IN A PERSISTENT VEGETATIVE STATE
    FOX, E
    STOCKING, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (21): : 2578 - 2582
  • [22] MANAGEMENT OF CONFLICTS WITH THE PARENTS OVER ADMINISTRATION OF LIFE-PROLONGING TREATMENT IN DUTCH NICUs
    Moratti, Sofia
    MEDICINE AND LAW, 2010, 29 (02): : 289 - 301
  • [23] Requests to forgo potentially life-prolonging treatment and to hasten death in terminally ill cancer patients: A prospective study
    Georges, JJ
    Onwuteaka-Philipsen, BD
    van der Heide, A
    van der Wal, G
    van der Maas, PJ
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 31 (02) : 100 - 110
  • [24] ANXIETY IN TERMINALLY ILL CANCER PATIENTS: PALLIATIVE VS LIFE-PROLONGING CARE
    Kolva, Elissa
    Rosenfeld, Barry
    Pessin, Hayley
    Breitbart, William
    Brescia, Robert
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 11 - 11
  • [25] Participation of chronically ill older adults in their life-prolonging treatment decisions: Rights and opportunity
    Shidler, S
    CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT, 1998, 17 (01): : 1 - 23
  • [26] EUTHANASIA, WITHHOLDING LIFE-PROLONGING TREATMENT, AND MORAL DIFFERENCES BETWEEN KILLING AND LETTING DIE
    GILLON, R
    JOURNAL OF MEDICAL ETHICS, 1988, 14 (03) : 115 - 117
  • [27] Capacity, Revisited: A Case Report of a Patient With Guardianship Who Refuses Life-Prolonging Treatment
    Sarkar, Pooja R.
    Mazur, Shannon L.
    DePergola, Peter A., II
    Kilpatrick, Walter J., III
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2021, 62 (01): : 79 - 82
  • [28] Determinants of acceptance of end-of-life interventions: a comparison between withdrawing life-prolonging treatment and euthanasia in Austria
    Stolz, Erwin
    Grossschaedl, Franziska
    Mayerl, Hannes
    Rasky, Eva
    Freidl, Wolfgang
    BMC MEDICAL ETHICS, 2015, 16
  • [29] Determinants of acceptance of end-of-life interventions: a comparison between withdrawing life-prolonging treatment and euthanasia in Austria
    Erwin Stolz
    Franziska Großschädl
    Hannes Mayerl
    Éva Rásky
    Wolfgang Freidl
    BMC Medical Ethics, 16
  • [30] The challenges of amnesia in assessing capacity, assigning a proxy, and deciding to forego life-prolonging medical treatment
    Myser, Catherine
    JOURNAL OF CLINICAL ETHICS, 2007, 18 (03): : 262 - 269